Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Altered expression of insulin receptor isoforms in breast cancer.

Huang J, Morehouse C, Streicher K, Higgs BW, Gao J, Czapiga M, Boutrin A, Zhu W, Brohawn P, Chang Y, Viner J, LaVallee T, Richman L, Jallal B, Yao Y.

PLoS One. 2011;6(10):e26177. doi: 10.1371/journal.pone.0026177. Epub 2011 Oct 26.

2.

Quantification of insulin receptor mRNA splice variants as a diagnostic tumor marker in breast cancer.

Aljada A, Saleh AM, Al-Aqeel SM, Shamsa HB, Al-Bawab A, Al Dubayee M, Ahmed AA.

Cancer Biomark. 2015;15(5):653-61. doi: 10.3233/CBM-150505.

PMID:
26406954
3.

[Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].

Zhang G, Li XP, Wang JL, Wei LH.

Zhonghua Fu Chan Ke Za Zhi. 2012 Nov;47(11):839-45. Chinese.

PMID:
23302125
4.
5.

Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.

Law JH, Habibi G, Hu K, Masoudi H, Wang MY, Stratford AL, Park E, Gee JM, Finlay P, Jones HE, Nicholson RI, Carboni J, Gottardis M, Pollak M, Dunn SE.

Cancer Res. 2008 Dec 15;68(24):10238-46. doi: 10.1158/0008-5472.CAN-08-2755.

6.

Quantitative determination of insulin-like growth factor 1 receptor mRNA in formalin-fixed paraffin-embedded tissues of invasive breast cancer.

Fu P, Ibusuki M, Yamamoto Y, Yamamoto S, Fujiwara S, Murakami K, Zheng S, Iwase H.

Breast Cancer. 2012 Oct;19(4):321-8. doi: 10.1007/s12282-011-0299-9. Epub 2011 Oct 12.

PMID:
21990036
7.

Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.

Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J.

Clin Cancer Res. 2005 Jun 15;11(12):4357-64.

8.

Differential gene expression induced by insulin and insulin-like growth factor-II through the insulin receptor isoform A.

Pandini G, Medico E, Conte E, Sciacca L, Vigneri R, Belfiore A.

J Biol Chem. 2003 Oct 24;278(43):42178-89. Epub 2003 Jul 24.

9.
10.

Quantifying insulin receptor isoform expression in FFPE breast tumors.

Harrington SC, Weroha SJ, Reynolds C, Suman VJ, Lingle WL, Haluska P.

Growth Horm IGF Res. 2012 Jun-Aug;22(3-4):108-15. doi: 10.1016/j.ghir.2012.04.001. Epub 2012 Apr 30.

11.

Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors.

Chettouh H, Fartoux L, Aoudjehane L, Wendum D, Clapéron A, Chrétien Y, Rey C, Scatton O, Soubrane O, Conti F, Praz F, Housset C, Rosmorduc O, Desbois-Mouthon C.

Cancer Res. 2013 Jul 1;73(13):3974-86. doi: 10.1158/0008-5472.CAN-12-3824. Epub 2013 Apr 30.

12.

Insulin-like growth factor I regulates the expression of isoforms of Wilms' tumor 1 gene in breast cancer.

Tuna M, Itamochi H.

Tumori. 2013 Nov-Dec;99(6):715-22. doi: 10.1700/1390.15461.

PMID:
24503796
13.

Insulin receptor isoforms A and B as well as insulin receptor substrates-1 and -2 are differentially expressed in prostate cancer.

Heni M, Hennenlotter J, Scharpf M, Lutz SZ, Schwentner C, Todenhöfer T, Schilling D, Kühs U, Gerber V, Machicao F, Staiger H, Häring HU, Stenzl A.

PLoS One. 2012;7(12):e50953. doi: 10.1371/journal.pone.0050953. Epub 2012 Dec 10.

14.

Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.

Cai D, Cao J, Li Z, Zheng X, Yao Y, Li W, Yuan Z.

BMC Cancer. 2009 Apr 1;9:102. doi: 10.1186/1471-2407-9-102.

15.

High IGF-IR activity in triple-negative breast cancer cell lines and tumorgrafts correlates with sensitivity to anti-IGF-IR therapy.

Litzenburger BC, Creighton CJ, Tsimelzon A, Chan BT, Hilsenbeck SG, Wang T, Carboni JM, Gottardis MM, Huang F, Chang JC, Lewis MT, Rimawi MF, Lee AV.

Clin Cancer Res. 2011 Apr 15;17(8):2314-27. doi: 10.1158/1078-0432.CCR-10-1903. Epub 2010 Dec 22.

16.

CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.

Olsson E, Honeth G, Bendahl PO, Saal LH, Gruvberger-Saal S, Ringnér M, Vallon-Christersson J, Jönsson G, Holm K, Lövgren K, Fernö M, Grabau D, Borg A, Hegardt C.

BMC Cancer. 2011 Sep 29;11:418. doi: 10.1186/1471-2407-11-418.

17.

Semaphorin-plexin signalling genes associated with human breast tumourigenesis.

Gabrovska PN, Smith RA, Tiang T, Weinstein SR, Haupt LM, Griffiths LR.

Gene. 2011 Dec 10;489(2):63-9. doi: 10.1016/j.gene.2011.08.024. Epub 2011 Sep 2.

PMID:
21925246
18.

Insulin receptor and glucose transporters mRNA expression throughout the menstrual cycle in human endometrium: a physiological and cyclical condition of tissue insulin resistance.

Mioni R, Mozzanega B, Granzotto M, Pierobon A, Zuliani L, Maffei P, Blandamura S, Grassi S, Sicolo N, Vettor R.

Gynecol Endocrinol. 2012 Dec;28(12):1014-8. doi: 10.3109/09513590.2012.705367. Epub 2012 Sep 12.

PMID:
22971162
19.

The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.

Chong YM, Colston K, Jiang WG, Sharma AK, Mokbel K.

Breast Cancer Res Treat. 2006 Oct;99(3):275-88. Epub 2006 Jun 5.

PMID:
16752221
20.

Overexpression of the insulin-like growth factor I receptor in human colon carcinomas.

Weber MM, Fottner C, Liu SB, Jung MC, Engelhardt D, Baretton GB.

Cancer. 2002 Nov 15;95(10):2086-95.

Supplemental Content

Support Center